Article Listing - FDA clears Avalide as initial high BP therapy

PHASE I RESULTS WITH BBG'S p24-VLP

9 March 1992

British Bio-technology Group of the UK has announced the completion of Phase I testing of its injectable AIDS immunotherapeutic product,...

MENINGITIS VACCINE IN CANADA

9 March 1992

Lederle Laboratories of Markham, Ontario, Canada, reports that it is now selling HibTITER in bulk form. The product represents a...

JAPAN, US, EURO PATENT AGREEMENT

9 March 1992

At a meeting late last month of the heads of the Japanese, US and European Patent Office, agreement was reached...

US SURGEONS SAY "FIRE KESSLER"

9 March 1992

The president of the American Society of Plastic and Reconstruct-ive Surgeons, Norman Cole, has written a letter urging more than...

AUSTRIA AMENDS MEDICINES ACT

9 March 1992

The Austrian Ministry of Health is drafting a second amendment of its Medicines Act, to achieve conformity with European Community...

UK NURSE PRESCRIBING MOVES

9 March 1992

Despite the speedy passage through Parliament of UK legislation to permit nurse prescribing, the enabling regulations are unlikely to be...

OTC HYOSCINE BUTYLBROMIDE LAUNCHED IN UK

9 March 1992

Windsor Healthcare, the pharmacy division of Boehringer Ingelheim Ltd, has launched Buscopan (hyoscine butylbromide) as an over-the-counter antispasmodic product in...

INTERPHARM AND rIL-6

9 March 1992

InterPharm Labs has receiv-ed conditional approval from Israel's Ministry of Industry and Trade to license Ares-Serono Group's worldwide rights to...

SURVIVAL TECH'S GEORGE WILKE

9 March 1992

George Wilke has joined Survival Technology Inc as senior vice president of pharmaceutical operations. He was previously vice president, operations,...

NEW CEO AT BOEH MANNHEIM CORP, USA

9 March 1992

Andre de Bruin is named president and chief executive officer of Boehringer Mannheim Corp, USA. He succeeds Robert Schwindt, who...

Showing 94691-94700 of 95316 articles